Combination of ICSs and LABAs should be used in the management of patients with COPD--the pro argument

Can Respir J. 2004 Apr;11(3):221-3. doi: 10.1155/2004/178072.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / therapeutic use*
  • Adrenergic beta-2 Receptor Agonists*
  • Clinical Trials as Topic
  • Delayed-Action Preparations / therapeutic use
  • Drug Therapy, Combination
  • Forced Expiratory Volume
  • Health Status
  • Humans
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Quality of Life*
  • Receptors, Adrenergic, beta-2 / therapeutic use*
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Agonists
  • Delayed-Action Preparations
  • Receptors, Adrenergic, beta-2